In the latest trading session,, 32.79 million BioNexus Gene Lab Corp (NASDAQ:BGLC) shares changed hands as the company’s beta touched 1.80. With the company’s most recent per share price at $15.06 changing hands around $11.99 or 390.49% at last look, the market valuation stands at $27.07M. BGLC’s last price was a premium, traded about 44.22% off its 52-week high of $8.40. The share price had its 52-week low at $2.01, which suggests the last value was 86.65% up since then. When we look at BioNexus Gene Lab Corp’s average trading volume, we note the 10-day average is 30310.0 shares, with the 3-month average coming to 622.40K.
BioNexus Gene Lab Corp (NASDAQ:BGLC) trade information
Instantly BGLC is in green as seen in intraday trades today. With action 463.97%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 226.64%, with the 5-day performance at 463.97% in the green. However, in the 30-day time frame, BioNexus Gene Lab Corp (NASDAQ:BGLC) is 251.00% up. Looking at the short shares, we see there were 15897.0 shares sold at short interest cover period of 0.13 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -21.27%.
BGLC Dividends
BioNexus Gene Lab Corp is expected to release its next quarterly earnings report in August.
BioNexus Gene Lab Corp (NASDAQ:BGLC)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 51.11% of BioNexus Gene Lab Corp shares while 0.88% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 1.80%.
Among Mutual Funds, the top two as of Apr 30, 2025 were Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund and Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St . With 2.37 shares estimated at $29967.0 under it, the former controlled 0.13% of total outstanding shares. On the other hand, Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St held about 0.00% of the shares, roughly 3.0 shares worth around $37.0.